H35.3124 Nonexudative age-related macular degeneration, left eye, advanced atrophic with subfoveal involvement

Name of the Condition

• Nonexudative Age-Related Macular Degeneration, Left Eye, Advanced Atrophic with Subfoveal Involvement

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp, detailed vision. This advanced atrophic form, also called "dry" AMD, involves significant macular thinning and drusen accumulation without fluid leakage or bleeding. Subfoveal involvement indicates damage directly beneath the fovea, the area critical for central vision, leading to progressive vision loss in the left eye.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the natural aging process of retinal cells. Key factors include the buildup of drusen (yellowish deposits) under the retina and oxidative stress, which can damage retinal tissues over time. Advanced atrophic changes occur as the macula thins and loses function, often with subfoveal involvement due to cumulative damage.

Risk Factors

• Increasing age, particularly over 50.
• Family history of macular degeneration.
• Smoking and tobacco exposure.
• Obesity and high cholesterol.
• Poor diet lacking antioxidants and zinc.
• Cardiovascular disease and hypertension.

Symptoms

• Blurred or reduced central vision in the left eye.
• Difficulty reading or recognizing faces.
• Need for brighter lighting when performing tasks.
• Distorted or wavy vision (less common in early stages).

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation to inspect the retina. Optical coherence tomography (OCT) provides detailed retinal layer imaging to confirm atrophic changes and subfoveal involvement. Fluorescein angiography may be used to rule out exudative components, and visual acuity testing assesses functional impact.

Treatment Options

• Antioxidant and zinc supplements (AREDS formula) to slow progression.
• Lifestyle modifications such as smoking cessation and diet improvement.
• Low-vision aids and rehabilitation for functional support.
• Regular monitoring for potential conversion to exudative AMD.

Prognosis and Follow-Up

Prognosis depends on the extent of atrophic changes and subfoveal involvement. Vision loss is typically gradual but may stabilize with advanced disease. Follow-up includes regular eye examinations, OCT scans, and visual acuity testing to monitor progression and adjust management as needed.

Complications

• Progressive central vision loss.
• Difficulty with daily tasks requiring detailed vision.
• Increased risk of developing exudative (wet) AMD in the same or fellow eye.

Lifestyle & Prevention

• Maintain a diet rich in leafy greens, fish, and antioxidants.
• Avoid smoking and limit alcohol consumption.
• Protect eyes from UV exposure with sunglasses.
• Manage cardiovascular risk factors like hypertension and cholesterol.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, such as blurring, distortion, or dark spots, as these may indicate progression to exudative AMD or other serious conditions.

Tips for Medical Coders

Document the presence of advanced atrophic changes and subfoveal involvement to support the specificity of H35.3124. Include clinical details confirming the absence of exudative features and the extent of macular involvement. Ensure documentation aligns with the left eye designation and advanced stage criteria.